Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020239 |
---|---|
Receipt number | R000023371 |
Scientific Title | Effects of Dapagliflozin on Body Weight in Japanese Patients with Type 2 Diabetes Mellitus. SUMS-ADDIT-2 |
Date of disclosure of the study information | 2015/12/21 |
Last modified on | 2022/07/12 09:23:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/12/17 10:14:11 | ||
2 | Update | 2016/04/13 10:00:49 | Recruitment status |
|
3 | Update | 2016/12/20 17:39:41 | Acronym |
|
4 | Update | 2016/12/20 17:46:33 | Key secondary outcomes Key secondary outcomes |
|
5 | Update | 2016/12/20 17:52:29 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
6 | Update | 2016/12/21 15:13:30 | Name of primary person or sponsor Organization Organization Organization Name of secondary funder(s) Name of secondary funder(s) |
|
7 | Update | 2017/02/02 10:39:13 | Organization Organization |
|
8 | Update | 2019/04/18 17:16:50 | UMIN ID1 |
|
9 | Update | 2019/04/28 18:39:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Tel1 Email1 Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Institutions |
|
10 | Update | 2019/04/28 19:12:05 | Date of IRB Last follow-up date Date trial data considered complete |
|
11 | Update | 2019/04/30 23:12:16 | Recruitment status |
|
12 | Update | 2022/06/28 16:50:35 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
13 | Update | 2022/07/12 09:23:18 | Recruitment status |